These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5450849)

  • 41. [A comparison of central visual field measurement by automated perimetry in optic neuritis due to multiple sclerosis and of unknown etiology].
    Fujimoto N
    Nippon Ganka Gakkai Zasshi; 1989 May; 93(5):581-6. PubMed ID: 2801361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Inflammations, vascular disorders, arachnitis in the peripheral visual pathway region].
    Nover A
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1974; 72():79-85. PubMed ID: 4480266
    [No Abstract]   [Full Text] [Related]  

  • 43. INTRAOCULAR OPTIC NEURITIS WITH NORMAL VISUAL ACUITY.
    DAROFF RB; SMITH JL
    Neurology; 1965 Apr; 15():409-12. PubMed ID: 14280606
    [No Abstract]   [Full Text] [Related]  

  • 44. Optic neuritis: clinical analysis of 27 cases.
    Bee YS; Lin MC; Wang CC; Sheu SJ
    Kaohsiung J Med Sci; 2003 Mar; 19(3):105-12. PubMed ID: 12751870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visual field defects in monocularly and binocularly deprived cats.
    Sherman SM
    Brain Res; 1973 Jan; 49(1):24-45. PubMed ID: 4698158
    [No Abstract]   [Full Text] [Related]  

  • 46. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.
    Beck RW; Gal RL; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Moke PS; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Trobe JD; Wall M; Xing D;
    Am J Ophthalmol; 2004 Jan; 137(1):77-83. PubMed ID: 14700647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visual function and pattern visual evoked response in optic neuritis.
    Sanders EA; Volkers AC; van der Poel JC; van Lith GH
    Br J Ophthalmol; 1987 Aug; 71(8):602-8. PubMed ID: 3651376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal Evaluation of Visual Function in Multiple Sclerosis.
    Narayanan D; Cheng H; Tang RA; Frishman LJ
    Optom Vis Sci; 2015 Oct; 92(10):976-85. PubMed ID: 26267060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Supraliminal contrast sensitivity functions in recovered optic neuritis.
    Tagami Y; Isayama Y; Masumi K; Bo H
    Jpn J Ophthalmol; 1982; 26(2):205-12. PubMed ID: 7131929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Color critical fusion frequency in the Bjerrum area. Comparison experiment of glaucoma with other cases].
    Yokoi T
    Nippon Ganka Gakkai Zasshi; 1972 Apr; 76(4):219-38. PubMed ID: 4672281
    [No Abstract]   [Full Text] [Related]  

  • 51. [Vision disturbances in optic neuritis].
    Khachaturova NK
    Vestn Oftalmol; 1973; 1():57-60. PubMed ID: 4777174
    [No Abstract]   [Full Text] [Related]  

  • 52. [Visual evoked potential and relative afferent pupillary defect in patients with unilateral optic neuritis].
    Nagashima Y; Kato M; Watanabe I
    Nippon Ganka Gakkai Zasshi; 1991 Oct; 95(10):1004-8. PubMed ID: 1746365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between static perimetry and the relative afferent pupillary defect.
    Kardon RH; Haupert CL; Thompson HS
    Am J Ophthalmol; 1993 Mar; 115(3):351-6. PubMed ID: 8442495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
    Arch Ophthalmol; 1997 Dec; 115(12):1545-52. PubMed ID: 9400788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Visual disturbances and chiasmal findings of SMON].
    Imachi J; Isayama Y; Monden M
    Nihon Ganka Kiyo; 1971 May; 22(5):294-304. PubMed ID: 5104938
    [No Abstract]   [Full Text] [Related]  

  • 56. Measurement of acuity variations within the central visual field caused by neurological lesions.
    Heron JR; Milner BA; Regan D
    J Neurol Neurosurg Psychiatry; 1975 Apr; 38(4):356-62. PubMed ID: 1141923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visual symptoms after optic neuritis: results from the Optic Neuritis Treatment Trial.
    Landau K
    Surv Ophthalmol; 1998; 42(5):491. PubMed ID: 9548579
    [No Abstract]   [Full Text] [Related]  

  • 58. Electrophysiological parameters in the evaluation of occipital apoplexy.
    Feinsod M; Hoyt WF; Wilson WB; Spire JP
    Eur Neurol; 1975; 13(5):451-60. PubMed ID: 1157816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.
    Keltner JL; Johnson CA; Cello KE; Dontchev M; Gal RL; Beck RW;
    Arch Ophthalmol; 2010 Mar; 128(3):330-7. PubMed ID: 20212204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute ganglion cell loss during rapid visual recovery in optic neuritis.
    Fukuchi M; Kishi S; Li D; Akiyama H
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2355-2360. PubMed ID: 27299339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.